Research programme: retinoids - Biomedica Life Sciences

Drug Profile

Research programme: retinoids - Biomedica Life Sciences

Alternative Names: RASP

Latest Information Update: 14 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biomedica Life Sciences
  • Developer Biomedica Life Sciences; University of Patras
  • Class Retinoids
  • Mechanism of Action Ribonuclease P inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Skin cancer

Most Recent Events

  • 14 Jul 2016 Preclinical trials in Skin cancer in Greece (unspecified route) before July 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top